Search
Nifurmerone
go.drugbank.com/drugs/DB20664ExperimentalNifurmerone is a small molecule drug. The usage of the INN stem 'nifur-' in the name indicates that Nifurmerone is a 5-nitrofuran derivative. … Nifurmerone has a monoisotopic molecular weight of 188.98 Da.
Synonyms: 5-nitro-2-furyl ketoneEdralbrutinib
go.drugbank.com/drugs/DB18095InvestigationalEdralbrutinib is an orally available small molecule inhibitor of Bruton's tyrosine kinase.
Synonyms: 4-amino-3-(4-(2,6-difluorophenoxy)phenyl)-1,6-dihydro-1-((3r)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl)-7h-pyrrolo(2,3-d)pyridazin-7-one, 7h-pyrrolo(2,3-d)pyridazin-7-one, 4-amino-3-(4-(2,6-difluorophenoxy)phenyl)-1,6-dihydro-1-((3r)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl)-(S)-famoxadone
go.drugbank.com/drugs/DB07778ExperimentalSynonyms: (S)-5-Methyl-5-(4-phenoxy-phenyl)-3-phenylamino-oxazolidine-2,4-dione, (S)-famoxadoneEzutromid
go.drugbank.com/drugs/DB12888InvestigationalEzutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.
Synonyms: 5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo(d)oxazole, Benzoxazole, 5-(ethylsulfonyl)-2-(2-naphthalenyl)-Categories: Heterocyclic Compounds, 2-RingDexfenfluramine
go.drugbank.com/drugs/DB01191ApprovedIllicitWithdrawnFor a fairly limited time during the middle of the nineties, the US FDA had approved it for use in managing weight loss. … Dexfenfluramine, also marketed under the name Redux, is a serotoninergic anorectic drug.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesSynonyms: d-N-ethyl-α-methyl-m-trifluoromethylphenethylamine, (S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-aminePentavalent Antimony
go.drugbank.com/drugs/DB13047InvestigationalPentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.
Synonyms: Antimony cation (5+)Tyrosyladenylate
go.drugbank.com/drugs/DB03325ExperimentalSynonyms: 5'-O-(L-Tyrosylsulfamoyl)adenosine(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide
go.drugbank.com/drugs/DB06837ExperimentalSynonyms: (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamideAvutometinib
go.drugbank.com/drugs/DB15254ApprovedInvestigational[L53203,L53198] The MAPK pathway is implicated in variety of cancers, playing a key role in tumor cell proliferation, differentiation and survival. … [A273948] Avutometinib was approved by the US FDA in May 2025 in a co-package alongside [defactinib] (called Avmapki Fakzynja) for the treatment of recurrent KRAS-mutated low-grade serous ovarian cancer
Synonyms: N-(3-fluoro-4-((4-methyl-2-oxo-7-((pyrimidin-2-yl)oxy)-2H-1-benzopyran-3-yl)methyl)pyridin-2-yl)-N'-methylsulfuric diamide, Sulfamide, N-(3-fluoro-4-((4-methyl-2-oxo-7-(2-pyrimidinyloxy)-2H-1-benzopyran-3-yl)methyl)-2-pyridinyl)-N'-methyl-Categories: Heterocyclic Compounds, 1-Ring, Cytochrome P-450 Substrates